Skip to main content

Table 2 Demographic characteristics of dogs enrolled in two clinical field studies in the northern and southern regions of Australia

From: Efficacy and safety of sarolaner (Simparica®) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia

Characteristic

Northern study

Southern study

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

(n = 55)

(n = 25)

(n = 50)

(n = 32)

Breed

 Purebred

19 (35%)

11 (44%)

26 (52%)

12 (38%)

 Non-purebred

36 (65%)

14 (56%)

24 (48%)

20 (63%)

Living condition

 Indoors and outdoors

30 (55%)

16 (64%)

18 (36%)

13 (41%)

 Mostly indoors

10 (18%)

3 (12%)

9 (18%)

6 (19%)

 Mostly outdoors

15 (27%)

6 (24%)

23 (46%)

13 (41%)

Sex

 Male

23 (42%)

14 (56%)

24 (48%)

20 (63%)

 Female

32 (58%)

11 (44%)

26 (52%)

12 (38%)

Neutered

 Yes

42 (76%)

19 (76%)

30 (60%)

22 (69%)

 No

13 (24%)

6 (24%)

20 (40%)

10 (31%)

Hair type

 Long

5 (9%)

5 (20%)

6 (12%)

3 (9%)

 Medium

19 (35%)

5 (20%)

19 (38%)

16 (50%)

 Short

31 (56%)

15 (60%)

25 (50%)

13 (41%)